Coverage Universe
Companies work with LifeSci Capital because of our distinct influence over investor engagement and behavior
Sort by Sector
Abivax
(ABVX.PA)
Analyst: Sam Slutsky
Immunology and Inflammation
absci
(ABSI)
Analyst: Rami Katkhuda
Dermatology
Achieve Life Sciences
(ACHV)
Analyst: Patrick Dolezal
CNS
Aclaris Therapeutics
(ACRS)
Analyst: Kate Dellorusso
Immunology and Inflammation
Adagene
(ADAG)
Analyst: Charles Zhu
Oncology
ADARx Pharmaceuticals
(ADRX)
Analyst: Sam Slutsky/Patrick Dolezal
Immunology and Inflammation
ALX Oncology
(ALXO)
Analyst: Sam Slutsky
Oncology
Amylyx Pharmaceuticals
(AMLX)
Analyst: Rami Katkhuda
Rare Disease
Apnimed
(APMD)
Analyst: Francois Brisebois
CNS
Aquestive Therapeutics
(AQST)
Analyst: Francois Brisebois
Immunology and Inflammation
Arcus Biosciences
(RCUS)
Analyst: Charles Zhu
Oncology
ArriVent BioPharma
(AVBP)
Analyst: Sam Slutsky
Oncology
Attovia Therapeutics
(ATTO)
Analyst: Sam Slutsky
Immunology and Inflammation
Aura Biosciences
(AURA)
Analyst: Oliver McCammon
Oncology
BlossomHill Therapeutics
(BLSM)
Analyst: Charles Zhu
Oncology
Bright Minds Biosciences
(DRUG)
Analyst: Francois Brisebois
CNS
Candel Therapeutics
(CADL)
Analyst: Oliver McCammon
Oncology
Celcuity
(CELC)
Analyst: Oliver McCammon
Oncology
Celldex
(CLDX)
Analyst: Sam Slutsky
Immunology and Inflammation
CG Oncology
(CGON)
Analyst: Sam Slutsky
Oncology
Cogent
(COGT)
Analyst: Sam Slutsky
Oncology
Compass Pathways
(CMPS)
Analyst: Francois Brisebois
CNS
Compass Therapeutics
(CMPX)
Analyst: Charles Zhu
Oncology
Context Therapeutics
(CNTX)
Analyst: Charles Zhu
Oncology
Contineum Therapeutics
(CTNM)
Analyst: Gaurav Maini
Rare Disease
Corbus Pharmaceuticals
(CRBP)
Analyst: Oliver McCammon
Oncology
Crescent Biopharma
(CBIO)
Analyst: Charles Zhu
Oncology
Damora Therapeutics
(DMRA)
Analyst: Sam Slutsky
Hematology
DBV Technologies
(DBVT)
Analyst: Sam Slutsky
Immunology and Inflammation
Definium Therapeutics
(DFTX)
Analyst: Francois Brisebois
CNS
Dianthus Therapeutics
(DNTH)
Analyst: Rami Katkhuda
Immunology and Inflammation
Disc Medicine
(IRON)
Analyst: Rami Kathkhuda
Hematology
Dyne Therapeutics
(DYN)
Analyst: Francois Brisebois
Rare Disease
Eledon Pharmaceuticals
(ELDN)
Analyst: Rami Katkhuda
Immunology and Inflammation
Eloxx Pharmaceuticals
(ELOX)
Analyst: Rami Katkhuda
Nephrology
Enliven Therapeutics
(ELVN)
Analyst: Sam Slutsky
Oncology
Entera Bio
(ENTX)
Analyst: Patrick Dolezal
Endocrinology
Eupraxia Pharmaceuticals
(EPRX)
Analyst: Sam Slutsky
Immunology and Inflammation
Faeth Therapeutics
(FTH)
Analyst: Oliver McCammon
Oncology
iBio
(IBIO)
Analyst: Patrick Dolezal
Cardiometabolic
IDEAYA Biosciences
(IDYA)
Analyst: Charles Zhu
Oncology
Immix Biopharma
(IMMX)
Analyst: Patrick Dolezal
Rare Disease
Immunic
(IMUX)
Analyst: Sam Slutsky
CNS
Immunome
(IMNM)
Analyst: Charles Zhu
Oncology
Immunovant
(IMVT)
Analyst: Sam Slutsky
Immunology and Inflammation
InflaRx
(IFRX)
Analyst: Sam Slutsky
Immunology and Inflammation
Inhibikase Therapeutics
(IKT)
Analyst: Gaurav Maini
Rare Disease
Inhibrx Biosciences
(INBX)
Analyst: Oliver McCammon
Oncology
Inventiva
(IVA)
Analyst: Rami Katkhuda
Immunology and Inflammation
IRulya Therapeutics
(IRLA)
Analyst: Sam Slutsky
Rare Disease
Jade Biosciences
(JBIO)
Analyst: Rami Katkhuda
Nephrology
Janux Therapeutics
(JANX)
Analyst: Oliver McCammon
Oncology
Kodiak Sciences
(KOD)
Analyst: Patrick Dolezal
Ophthalmology
Korro Bio
(KRRO)
Analyst: Thibaut R. Pardo-Garcia
Genetic Medicines
Kura Oncology
(KURA)
Analyst: Charles Zhu
Oncology
Larimar Therapeutics
(LRMR)
Analyst: Francois Brisebois
Rare Disease
Liquidia
(LQDA)
Analyst: Gaurav Maini
Rare Disease
MapLight Therapeutics
(MPLT)
Analyst: Francois Brisebois
CNS
Maze Therapeutics
(MAZE)
Analyst: Rami Katkhuda
Nephrology
MBX Biosciences
(MBX)
Analyst: Patrick Dolezal
Endocrinology
Mereo BioPharma
(MREO)
Analyst: Kate Dellorusso
Rare Disease
Mineralys Therapeutics
(MLYS)
Analyst: Rami Katkhuda
Cardiometabolic
Molecular Partners
(MOLN)
Analyst: Charles Zhu
Oncology
Monte Rosa Therapeutics
(GLUE)
Analyst: Oliver McCammon
Immunology and Inflammation
MoonLake Immunotherapeutics
(MLTX)
Analyst: Rami Kathkhuda
Immunology and Inflammation
Neurogene
(NGNE)
Analyst: Patrick Dolezal
Rare Disease
Obsidian Therapeutics
(OBX)
Analyst: Sam Slutsky
Oncology
Oculis
(OCS)
Analyst: Patrick Dolezal
Ophthalmology
Olema Pharmaceuticals
(OLMA)
Analyst: Sam Slutsky
Oncology
OnKure
(OKUR)
Analyst: Sam Slutsky
Oncology
Opus Genetics
(IRD)
Analyst: Francois Brisebois
Ophthalmology
Oruka Therapeutics
(ORKA)
Analyst: Sam Slutsky
Immunology and Inflammation
Ovid Therapeutics
(OVID)
Analyst: Francois Brisebois
CNS
Palvella Therapeutics
(PVLA)
Analyst: Sam Slutsky
Rare Disease
Parabilis Medicines
(PBLS)
Analyst: Charles Zhu
Oncology
Perspective Therapeutics
(CATX)
Analyst: Oliver McCammon
Oncology
Praxis Precision Medicines
(PRAX)
Analyst: Francois Brisebois
CNS
Prime Medicine
(PRME)
Analyst: Thibaut R. Pardo-Garcia
Genetic Medicines
Protara Therapeutics
(TARA)
Analyst: Charles Zhu
Oncology
Pyxis Oncology
(PYXS)
Analyst: Sam Slutsky
Oncology
Revolution Medicines
(RVMD)
Analyst: Charles Zhu
Oncology
Rocket Pharmaceuticals
(RCKT)
Analyst: Patrick Dolezal
Rare Disease
Satellos Bioscience
(MSLE)
Analyst: Francois Brisebois
Rare Disease
Savara
(SVRA)
Analyst: Francois Brisebois
Rare Disease
Sionna Therapeutics
(SION)
Analyst: Gaurav Maini
Rare Disease
Sol-Gel Technologies
(SLGL)
Analyst: Patrick Dolezal
Rare Disease
Spyre Therapeutics
(SYRE)
Analyst: Sam Slutsky
Immunology and Inflammation
Structure Therapeutics
(GPCR)
Analyst: Patrick Dolezal
Cardiometabolic
Surrozen
(SRZN)
Analyst: Patrick Dolezal
Ophthalmology
Sutro Biopharma
(STRO)
Analyst: Charles Zhu
Oncology
Tarsus Pharmaceuticals
(TARS)
Analyst: Francois Brisebois
Ophthalmology
Tectonic Therapeutic
(TECX)
Analyst: Gaurav Maini
Cardiopulmonary
Tenax Therapeutics
(TENX)
Analyst: Gaurav Maini
Cardiopulmonary
Tenaya Therapeutics
(TNYA)
Analyst: Thibaut R. Pardo-Garcia
Genetic Medicines
TScan Therapeutics
(TCRX)
Analyst: Sam Slutsky
Oncology
Upstream Bio
(UPB)
Analyst: Kate Dellorusso
Immunology and Inflammation
Vera Therapeutics
(VERA)
Analyst: Rami Katkhuda
Nephrology
Veradermics
(MANE)
Analyst: Rami Katkhuda
Dermatology
Viridian Therapeutics
(VRDN)
Analyst: Rami Katkhuda
Immunology and Inflammation
vTv Therapeutics
(VTVT)
Analyst: Patrick Dolezal
Cardiometabolic
Yarrow Bioscience
(YARW)
Analyst: Rami Katkhuda
Immunology and Inflammation
Zymeworks
(ZYME)
Analyst: Charles Zhu